Cullinan Therapeutics, Inc. · NASDAQ:CGEM

Citadel Advisors LLC reported a 5.10% stake in Cullinan Therapeutics, Inc. (Schedule 13G)

Event Jul 30, 2025 · Filed Aug 6, 2025

Citadel Advisors LLC reported a 5.10% stake in Cullinan Therapeutics, Inc., 3,009,126 shares, as a passive investor on Jul 30, 2025. Filed Aug 6, 2025 (Schedule 13G).

Stake
5.10%
Shares
3,009,126
Intent
Passive
What changed
Crossed above 5%
Filed together
7 holders

The filing in full

HolderStakeShares
Citadel Advisors LLC4.30%2,511,191
Citadel Advisors Holdings LP4.30%2,511,191
Citadel GP LLC4.30%2,511,191
Citadel Securities LLC0.80%497,935
Citadel Securities Group LP0.80%497,935
Citadel Securities GP LLC0.80%497,935
Kenneth Griffin5.10%3,009,126

Source

View original at SEC

Related